<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05107245</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A00979-30</org_study_id>
    <nct_id>NCT05107245</nct_id>
  </id_info>
  <brief_title>Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.</brief_title>
  <acronym>EDIFICE</acronym>
  <official_title>Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of French People Infected With the SARS-CoV-2.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luxia Scientific</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinique Saint Jean Ermitage</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier de Fontainebleau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinique du Mousseau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Luxia Scientific</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the context of the COVID-19 pandemic, the role of the gut microbiome is yet unknown. The&#xD;
      aim of this trial is to evaluate the clinical contribution of the gut microbiome composition&#xD;
      and diversity on the disease severity and to estimate the viral load in stool samples.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 28, 2020</start_date>
  <completion_date type="Actual">May 31, 2021</completion_date>
  <primary_completion_date type="Actual">April 29, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Alpha-diversity</measure>
    <time_frame>at the time of inclusion in the study</time_frame>
    <description>Alpha-diversity of the gut microbiota measured by 16S sequencing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SARS-CoV-2 load</measure>
    <time_frame>at the time of inclusion in the study</time_frame>
    <description>SARS-CoV-2 load in stool measured by RT-PCR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiome composition</measure>
    <time_frame>at the time of inclusion in the study</time_frame>
    <description>Genus level of the gut microbiota measured by 16S sequencing</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">143</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>COVID-19 patients</arm_group_label>
    <description>Hospitalised COVID-19 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Exposed medical staff</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>1test1</intervention_name>
    <description>Loss of bacterial diversity diagnosis</description>
    <arm_group_label>COVID-19 patients</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        COVID-19 positive patients: hospitalised patients diagnosed with COVID-19 in one of the&#xD;
        investigating sites, and able to provide a stool sample.&#xD;
&#xD;
        + Control subjects: Medical and paramedical personnel working at one of the investigating&#xD;
        sites, having been in direct contact with the patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  COVID-19 positive patients: hospitalised patients diagnosed with COVID-19 in one of&#xD;
             the investigating sites, and able to provide a stool sample.&#xD;
&#xD;
          -  Control subjects: Medical and paramedical personnel working at one of the&#xD;
             investigating sites, having been in direct contact with the patients.&#xD;
&#xD;
          -  Aged between 18 and 95 years.&#xD;
&#xD;
          -  Subjects able to read the French-language study information leaflet.&#xD;
&#xD;
          -  Patients with social cover.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  COVID-19 negative patients.&#xD;
&#xD;
          -  Patients in resuscitation, heart failure or respiratory failure.&#xD;
&#xD;
          -  Unable to provide naturally a stool sample.&#xD;
&#xD;
          -  Patients without social cover.&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nantes</name>
      <address>
        <city>Nantes</city>
        <state>Pays De La Loire</state>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Fontainebleau</name>
      <address>
        <city>Fontainebleau</city>
        <state>Seine-et-Marne</state>
        <zip>77300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Jean l'Ermitage</name>
      <address>
        <city>Melun</city>
        <state>Seine-et-marne</state>
        <zip>77000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Mousseau</name>
      <address>
        <city>Évry-Courcouronnes</city>
        <state>Île De France</state>
        <zip>91000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 22, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>microbiome ; SARS-CoV-2 ; metagenomic ; stool</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

